Patient P-03363
Therapy response
Favorable
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
44%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S20
- Day 81 AD-05 recommended — Adherence Support AD-05
- Day 82 Patient declined — Not now
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+16
- Inflammatory activity+12
- Nutritional resilience-8
- Treatment adherence-4
- Toxicity+3
What helped?
- Adherence Support AD-05Day 81Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑15
- WearableHRV 37 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.1 · butyrate capacity 76/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 40 ms
- Sleep
- 7.5 h
- Steps
- 7,168
- Resting HR
- 65 bpm
Daily log: GI score 37, nutritional resilience 57, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03482 | 44% | S05 | AD-05 | no change | 67 |
| P-03105 | 43% | S12 | AD-05 | no change | 60 |
| P-03187 | 33% | S12 | AD-05 | no change | 80 |
| P-03204 | 33% | S16 | AD-05 | improved | 48 |
| P-03424 | 32% | S12 | AD-05 | improved | 41 |
| P-03351 | 30% | S07 | AD-05 | no change | 51 |
| P-03111 | 29% | S07 | AD-05 | no change | 48 |
| P-03208 | 35% | S02 | BR-03 | improved | 57 |
| P-03277 | 31% | S14 | BR-03 | improved | 41 |
| P-03308 | 29% | S04 | BR-03 | improved | 39 |
| P-03484 | 35% | S07 | DT-01 | improved | 49 |
| P-03244 | 34% | S08 | DT-01 | improved | 53 |